four patients with the Farmos or the Boot-Ceiltech assay, in both of which mouse serum or mouse immunoglobthins are included. The Behring assay, which includes rat serum, showed no interference with the three sera that over-reacted in the Serono assay. However, the rat serum was unable to neutralize immunoglobulin-bmnding substances in the serum of patient 4.
Disturbed Melatonin Secretion in Chronic Alcoholism and Withdrawal

To the Editor:
The pineal gland is increasingly regarded as an endocrine organ of clinical importance (1-3). Assay of the principal pineal factor, melatonin, is the best currently available peripheral index of pineal function in humans (4), and many reports document abnormalities inmelatoninsecretion withinseveral clinical categories, most notably the affective disorders (5) and certain neoplastic diseases (1, 2, 6). Within a wider investigation of useful neuroendocrine markers of chronic alcoholism, we studied 28 male chronic alcoholics (agerange 23-62 y, mean 43.8 y) for abnormal pineal function by screening for afternoon melatonin secretion at 15:00hours,a time when normal melatoninsecretion isundetectable by most current radioimmunoassays (2, 3). All patients had a historyofaveragedaily ethanol intake of >100 g for 7-41 years. Unequivocal alcohol dependence was recorded on admission, and the alcohol withdrawal syndrome was later observed in all patients. Melatonin was assayed by direct radioimmunoassay (7) of plasma collected at 15:00 hours on admission and after conventional therapy. 
A Comment on the "Albumin Effect" in Analog Free-Thyroxin Determinations
To the Editor: Several reports (1-6) concern the dependency on albumin concentration of analog free-thyroxin (Fr4) assay kits (especially Amerlex FF4). They con- dude that the analog method is highly sensitive to variations in albumin concentration in serum, and in some cases went so far as to suggest that the analog free-hormone methods should be excluded from the clinical laboratory (7) . However, does the evidence truly show that the analog methods are inappropriate and inaccurate techniques for FF4 measurement, and are experiments involving added albumin always likely to parallel effects of endogenous albumin in serum?
We examined the response of the Anierlex Fr4 radioimmunoassay kit to increasing concentrations of human serum albumin obtained from four different commercial sources (seven batches):
Sp.cIBatch man no.
Company no.
1.
Tokyo Kasei Co. A194
2. Sigma Chemical Co.
91 F-9340 3.
Tokyo Kasei Co.
A197
4.
Green Cross Co.
TO-OO2TF
5.
Sigma Chemical Co. 108 C-8085 6.
Cappel Co.
18143
7.
Cappel Co. 16565
In addition, we treated a batch of albumin (Sigma) by Ishibashi's method, a modification of Mitsuma's method (8) , to dissociate T4 and other bound molecules, and compared the sensitivity of the treated and untreated batches in the FF4 assay. The most striking feature of the results (Figure 1) is the considerable variability in the effects of albumin from different commercial sources on the Amerlex FF4 assay. The Fr4 concentrationwas found to decrease after T4 dissociation. These results reveal that the albumin concentration per so does not strongly affect the determination, but that the Fr4 value mainly depends on albumin-bound T4. Apparent rate changes in the spurious "detection"of Fr4 ranged from 50 to 400 pg (65 to 500 pmol) of apparent Fr4 per liter for each gram of albumin added per liter. In addition, the treated Sigma specimen of albumin gave an effect equivalent to the loWest rate of increase in apparent Fr4, whereas before treatment the rate was about 150 pg/L (0.2 pmol/L) per gram of albumin per liter.
No doubt some of these effects could be due to small amounts ofT4 present in variable quantity in the albumin specimens, but we could not detect any T4 by direct RIA, so there is also a possibility that the various albumin batches were purified by different techniques and thus had different conformations and affinities for the T4 analog intheFr4 kit. Itisinteresting thatthe lowest effect(65 fmol/L) is closely equivalent tothe effect estimatedfrom invivo studies ofthedependenceofthe Amerlex Fr4 values on albumin concentrations in serum (9, 10) . We believe that those studies implying severe albumin effects in vivo on the Amerlex analog Fr4 kit should be regarded with great caution because of thedemonstrablevariability ofinvitro albumin effects. From the clinical point ofview itisvaluabletobe abletofind low yr4 values in severe nonthyroidal illness, because it is well established that the low-T4 syndrome in severe illness is associated with a poor prognosis (11, 12) included in the product literature (3) and in a scientific paper (4) . It was also described and included in our 1985 mass-action study (5) . In contrast to Dr. Ross' speculation (2), we found no evidence that this quantity leads to a distortion of binding-protein equilibria sufficient to invalidate the assay (4,5).
Apart from decreasing the sensitiv- The above observations present an interesting dilemma for free hormone assay workers in the commercial sector. It is now possible to synthesize analogs (11) or pseudo-analogs (12, 13) that are unreactive with serum proteins. Assays using these tracers do not require extra albumin in the buffers and yet are free ofalbumin effects (11). Without extra albumin, these assays, like equilibrium dialysis (9), will be susceptible to NEFA. If the prevailing simplistic view of normal ranges is followed, then, like dialysis, these assays will compromise diagnostic sensitivity in favor of diagnostic specificity (9, 10) . Alternatively, extra albumin could be used to sequester NEFA and improve diagnostic sensitivity, but at the expense of specificity. Similar considerations also apply for the better non-analog methods. If a technologically "purist" approach is preferred to diagnostic pragmatism, it should be recognized that the resulting assays will be fragile. Beck et al.
(1) reported a significant (P <0.01) relationship between the concentrations in serum of free T4 as measured by an improved ligand-analog RIA and of albumin (method not stated). They used a polynomial regressionofthefourthdegree in their statistical analysis. Their results indicated a direct relationship between free T4 and albumin in the 16-28 g/L albumin range. These authors concluded that their data showed "the invalidity of the (free T4) assay in the low-abnormal range of serum albumin."
The mere fact that they had to resort to as high an order as the fourth degree in their regression equation might have led them to suspect that other factors than the albumin concentration were responsible. As summarized previously (2) , it is in fact impossible to assess thyroid function in severely sick patients, e.g., critically ill, such as those studied by Beck et al. This is due to several factors-metabolic changes in, and adaptations to disease (suminarized in refs. 3 and 4) and influence by drug treatment.
We feel that statistical analysis should be an adjunct to, rather than
